Developing clinically pertinent patient-derived xenograft (PDX) models, using serum prostate specific antigen (PSA) levels and tumor volume as key indicators, can better mimic ADT-induced dormancy in the clinic 32, 39, 40. Here, KLK3 is linked to neoplasm.